Stingray Therapeutics
Stingray Therapeutics
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) | Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) | Recruiting | Phase 2 | 2026-08-12 | NCT06589440 | |
| A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors | Disease Attributes, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, neoplasm | Recruiting | Phase 1 | 2025-06-08 | NCT06063681 |